top of page

Focus on lithium 

Lithium is a mood stabilising drug used in the following situations 

  • Prevention and treatment of mania 

  • Prevention of bipolar disorder (manic depressive disorder) : decreasing the no: and severity of relapses. or effective in preventing MANIC relapses compared to DEPRESSIVE relapses 

  • Combination therapy

  • Prevention of recurrent depression 

  • Augmentation thearpy in treatment resistant depression 

 

​Lithium is a drug with a narrow therapeutic window 

Target levels 0.4 -  1.0 mmol/l

Exists as lithium carbonate and lithium citrate 

Up to 1.2mmol/l in acute manic episodes

Overdose:  > 1.5mmol/l may be fatal

Following release from formulation, lithium is rapidly & completely absorbed.

Treatment and prophylaxis of bipolar disorder (manic depressive disorder)

 

The effects of lithium prophylaxis may not be exerted for 6-12 months post therapy initiation. 

 

 

Chronic use of lithium: 

Is associated with thyroid disorders and mild cognitive and memory impairment 

Should be undertaken with careful risk and benefit assessments 

Requires thyroid function monitoring every 6 months (should be more regularly monitored if thyroid function deteriorates) 

 

 

Monitoring 

Click here to see what monitoring is required for lithium and other drugs used in bipolar 

 

 

Adverse effects 

  • Adverse effects are usually dose dependant, these include:

  • Gastrointestinal disturbances, 

  • Polyuria (occurs with twice a day dosing)

  • Polydypsia 

  • Psoriasis and acne may be worsened by the use of lithium 

​

Interactions of lithium with: 

 

  • Diuretics:  Frequent use  (especially thiazide diuretics) is hazardous and must be avoided as lithium toxicity is worsened by decreased sodium levels 

  • ACE inhibitors: decrease lithium excretion causing increased lithium concentration 

  • Analgesics:   e.g. NSAIDs also reduce lithium excretion which increases the risk of lithium toxicity (this is the same for ketorolac therefore concomitant use must be avoided) 

  • Venlafaxine:  there's  a possibility of increased serotonergic effects

  • SSRIs: lithium toxicity has been reported. There's an increased risk of CNS effects

  • TCAs: there's a risk of toxicity 

 

Lithium in: 

Pregnancy:  

 

  • Must be avoided, especially in the 1st trimester unless necessary : risks include teratogenicity 

       and cardiac abnormalities 

  • During the  2nd and 3rd semester, the dose is increased

  • Post delivery, the normal dose is administered thereafter 

​

​Breast feeding :

AVOID as present in milk and there is risk of TOXICITY in neonate

 

Renal impairment:

If possible lithium should be avoided in renal patients, or the dose should be reduced and serum-lithium concentration should be monitored  because lithium is renally excreted 

 

Lithium overdose 

  • Lithium overdose in any patient who is taking it long term can be potentially serious 

  • A once off overdose is usually deemed to be low risk where patients will suffer from mild-moderate symtoms regardless of their serum lithium concentration 

  • However, severe symptoms can arise if lithium elimination s reduced due to renal impairment especially if a slow release formulation has been modified . A fatal dose (of  a single administration) is thought to be approximately over 5g. 

 

Lithium toxicity can also occur in (chronic accumulation) from the following situations: 

  • Acute/chronic overdose 

  • Dehydration 

  • Worsening/poor renal function 

  • Drug interactions: typically where a Non Steroidal Anti-Inflammatory Drugs  (NSAID) or a thiazide diuretic is involved 

 

Patients with a high lithium serum concentration are at a greater risk of suffering from toxicity if they suffer from any of the following

  • Hypertension 

  • Diabetes 

  • Schizophrenia 

  • Addison's disease 

  • Congestive heart failure 

 

Symptoms of lithium toxicity 

Mild lithium toxicity 

  • Nausea 

  • Diarrhoea 

  • Blurred vision 

  • Drowsiness 

  • Dizziness 

  • Muscle weakness 

 

Moderate lithium toxicity 

  • Hypernatraemia 

  • More confusion 

  • Myoclonic twitching and jerking 

  • Urinary incontinence 

  • Blackouts  

  • Hypernatraemia 

  • Increased deep tendon reflexes

  • Increased restlessness followed by stupor 

 

Severe lithium toxicity 

  • Coma

  • Hypotension 

  • Rarely hypertension 

  • Convulsions 

  • Cerebellar signs 

  • Renal failure 

  • Circulatory collapse 

  • Cardiac dysrhythmias including sino-atrial block,

  • Sinus and junctional bradycardia and first degree heart block.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

 

 

Patients taking lithium should be given a lithium treatment pack, consisting of the following: 

  • Patient information booklet:  this contains information educating the patient about lithium, how and when to take it, blood levels frequency, contraception, pregnancy, and other important considerations are also explained. 

​

Lithium alert card:  this must be carried by the patient at ALL times. This card contains the following information:

  • Patient name and address, with a contact number 

  • GP name and NHS number 

  • Date of treatment commencing , 

  • Type of brand, formulation, and daily dose

  • Contact details of the support team, hospital and clinic   

Record book: Patients must take this along with the to the following: 

  • GP surgery 

  • clinics

  • when admitted to hospital

  • when visiting the pharmacy

It contains the following information : 

  • Date of subsequent lithium blood test 

  • Health check records 

  • Previous lithium blood levels

  • Health monitoring and lithium therapy  â€‹

bottom of page